New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

The preparation and evaluation of a novel class of CB2 agonists based on a 1,2,3,4-tetrahydropyrrolo[3,4-b]indole moiety are reported. They showed binding affinities up to 4.2 nM toward CB2 with sub-nanomolar EC(50) values. They also showed moderate to good (>350-fold) selectivity over the CB1 receptor.

Knowledge Graph

Similar Paper

New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel benzimidazole derivatives as selective CB2 agonists
Bioorganic & Medicinal Chemistry Letters 2008.0
Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB<sub>2</sub>Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling
Journal of Medicinal Chemistry 2006.0
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Design, Synthesis, and Biological Evaluation of New 1,8-Naphthyridin-4(1H)-on-3-carboxamide and Quinolin-4(1H)-on-3-carboxamide Derivatives as CB<sub>2</sub>Selective Agonists
Journal of Medicinal Chemistry 2006.0
Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB<sub>2</sub> Cannabinoid Receptor Activity
Journal of Medicinal Chemistry 2008.0
Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands
European Journal of Medicinal Chemistry 2014.0
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: A versatile architecture for CB2 selective ligands
European Journal of Medicinal Chemistry 2014.0
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB<sub>2</sub>Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists
Journal of Medicinal Chemistry 2012.0